checkAd

     167  0 Kommentare Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1 Watch for Consumers

    Masimo (NASDAQ: MASI) marks its 33rd anniversary today by announcing the limited market release of the W1 health watch for consumers. The first of its kind, the Masimo W1 offers accurate, continuous measurements and actionable health insights – from the leader in hospital pulse oximetry – in a personal, discreet, lifestyle-friendly wrist-worn wearable. Building on Masimo’s decades of leadership in creating revolutionary noninvasive blood parameter monitoring solutions, W1 provides accurate, continuous monitoring of multiple health parameters – including oxygen saturation (SpO2), pulse rate, perfusion index, PVi, and respiration rate, alongside step count and fall detection.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220502005318/en/

    Masimo W1 (Photo: Business Wire)

    Masimo W1 (Photo: Business Wire)

    Incorporated on May 2, 1989 as a garage startup dedicated to solving the “unsolvable” problem of inaccurate and unreliable conventional pulse oximetry under real-life conditions such as patient movement, Masimo and its breakthrough Measure-through Motion and Low Perfusion SET pulse oximetry today touch hundreds of millions of lives around the world each year.1 SET pulse oximetry has been shown in more than 100 independent studies to outperform other pulse oximetry technologies,2 and is the only pulse oximetry shown in numerous large studies – involving more than 300,000 infants – to improve critical congenital heart disease (CCHD) screening in newborns.3-13 SET pulse oximetry has also been shown to improve outcomes for patients on opioids in post-surgical wards,14-17 reduce eye damage and blindness in the neonatal intensive care unit,18 and reduce mortality among Covid patients remotely monitored at home.19 Through Masimo’s continued focus on innovation and improvement, SET has evolved to feature the industry’s highest accuracy specifications, on the new RD line of patient sensors; become tetherless, with the secure Bluetooth-equipped continuous Radius PPG; and now, as the foundational technology driving the W1, has become a truly lifestyle-friendly technology for consumers outside hospitals.

    Seite 1 von 5



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1 Watch for Consumers Masimo (NASDAQ: MASI) marks its 33rd anniversary today by announcing the limited market release of the W1 health watch for consumers. The first of its kind, the Masimo W1 offers accurate, continuous measurements and actionable health insights – from …

    Schreibe Deinen Kommentar

    Disclaimer